Description

This program will cover key clinical trial findings and their implications from AHA 2024. This program is intended for cardiovascular specialists and primary care physicians from across Canada.

Learning objectives:

Following participation in this program, participants will be able to:

• Identify the clinical implications of the new data presented at AHA 2024
• Examine where the data presented may impact clinical practice guidelines
• Apply the latest evidence-based strategies in clinical practice

Faculty

Milan Gupta, MD, FRCPC, FCCS, CPC(HC)

Narendra Singh, MD, FRCPC, FCCS, FACC, FAHA

This program is developed by CCRN and has received unrestricted educational grant funding.